Sample composition and referral type that led most directly to the cancer diagnosis (N = 17 042)
| Total of NCDA n (%) | TWW n (%) | Urgenta n (%) | Routine n (%) | Screening n (%) | Emergencyb n (%) | To private care n (%) | Other n (%) | Not known n (%) | |
|---|---|---|---|---|---|---|---|---|---|
| Total | 17 042 (100.0) | 8820 (51.8) | 745 (4.4) | 1346 (7.9) | 1237 (7.3) | 2818 (16.5) | 315 (1.8) | 1004 (5.9) | 757 (4.4) |
| Male | 8544 (50.1) | 4482 (52.5) | 436 (5.1) | 829 (9.7) | 145 (1.7) | 1474 (17.3) | 187 (2.2) | 549 (6.4) | 442 (5.2) |
| Female | 8498 (49.9) | 4338 (51.0) | 309 (3.6) | 517 (6.1) | 1092 (12.9) | 1344 (15.8) | 128 (1.5) | 455 (5.4) | 315 (3.7) |
| Age group, years | |||||||||
| 0–24 | 198 (1.2) | 46 (23.2) | 14 (7.1) | 16 (8.1) | 2 (1.0) | 94 (47.5) | 4 (2.0) | 9 (4.5) | 13 (6.6) |
| 25–49 | 1705 (10.0) | 951 (55.8) | 73 (4.3) | 162 (9.5) | 113 (6.6) | 208 (12.2) | 67 (3.9) | 59 (3.5) | 72 (4.2) |
| 50–64 | 4144 (24.3) | 2144 (51.7) | 153 (3.7) | 318 (7.7) | 561 (13.5) | 509 (12.3) | 107 (2.6) | 201 (4.9) | 151 (3.6) |
| 65–74 | 4877 (28.6) | 2532 (51.9) | 228 (4.7) | 423 (8.7) | 473 (9.7) | 655 (13.4) | 73 (1.5) | 313 (6.4) | 180 (3.7) |
| 75–84 | 4213 (24.7) | 2274 (54.0) | 198 (4.7) | 326 (7.7) | 79 (1.9) | 797 (18.9) | 42 (1.0) | 281 (6.7) | 216 (5.1) |
| ≥85 | 1905 (11.2) | 873 (45.8) | 79 (4.1) | 101 (5.3) | 9 (0.5) | 555 (29.1) | 22 (1.2) | 141 (7.4) | 125 (6.6) |
| Cancer site | |||||||||
| Bladder | 490 (2.9) | 308 (62.9) | 26 (5.3) | 39 (8.0) | 2 (0.4) | 61 (12.4) | 7 (1.4) | 25 (5.1) | 22 (4.5) |
| Brain | 265 (1.6) | 23 (8.7) | 19 (7.2) | 11 (4.2) | 0 (0.0) | 172 (64.9) | 4 (1.5) | 16 (6.0) | 20 (7.5) |
| Breast | 2714 (15.9) | 1533 (56.5) | 30 (1.1) | 46 (1.7) | 918 (33.8) | 56 (2.1) | 35 (1.3) | 50 (1.8) | 46 (1.7) |
| Cancer of unknown primary | 400 (2.3) | 137 (34.2) | 21 (5.2) | 20 (5.0) | 3 (0.8) | 160 (40.0) | 3 (0.8) | 25 (6.2) | 31 (7.8) |
| Colon | 1320 (7.7) | 543 (41.1) | 63 (4.8) | 100 (7.6) | 122 (9.2) | 350 (26.5) | 31 (2.3) | 57 (4.3) | 54 (4.1) |
| Endometrial | 400 (2.3) | 311 (77.8) | 14 (3.5) | 23 (5.8) | 1 (0.2) | 26 (6.5) | 10 (2.5) | 8 (2.0) | 7 (1.8) |
| Leukaemia | 470 (2.8) | 96 (20.4) | 30 (6.4) | 79 (16.8) | 4 (0.9) | 165 (35.1) | 9 (1.9) | 45 (9.6) | 42 (8.9) |
| Liver | 272 (1.6) | 87 (32.0) | 14 (5.1) | 23 (8.5) | 7 (2.6) | 86 (31.6) | 4 (1.5) | 32 (11.8) | 19 (7.0) |
| Lung | 2132 (12.5) | 976 (45.8) | 95 (4.5) | 89 (4.2) | 14 (0.7) | 625 (29.3) | 9 (0.4) | 212 (9.9) | 112 (5.3) |
| Lymphoma | 739 (4.3) | 347 (47.0) | 57 (7.7) | 81 (11.0) | 2 (0.3) | 143 (19.4) | 21 (2.8) | 53 (7.2) | 35 (4.7) |
| Melanoma | 836 (4.9) | 611 (73.1) | 22 (2.6) | 113 (13.5) | 2 (0.2) | 4 (0.5) | 16 (1.9) | 45 (5.4) | 23 (2.8) |
| Multiple myeloma | 272 (1.6) | 84 (30.9) | 24 (8.8) | 39 (14.3) | 3 (1.1) | 76 (27.9) | 2 (0.7) | 23 (8.5) | 21 (7.7) |
| Oesophageal | 447 (2.6) | 281 (62.9) | 19 (4.3) | 35 (7.8) | 8 (1.8) | 65 (14.5) | 5 (1.1) | 17 (3.8) | 17 (3.8) |
| Oral/oropharyngeal | 268 (1.6) | 160 (59.7) | 12 (4.5) | 20 (7.5) | 0 (0.0) | 17 (6.3) | 9 (3.4) | 19 (7.1) | 31 (11.6) |
| Other | 1582 (9.3) | 728 (46.0) | 93 (5.9) | 194 (12.3) | 72 (4.6) | 240 (15.2) | 32 (2.0) | 130 (8.2) | 93 (5.9) |
| Ovarian | 332 (1.9) | 192 (57.8) | 15 (4.5) | 11 (3.3) | 1 (0.3) | 81 (24.4) | 7 (2.1) | 11 (3.3) | 14 (4.2) |
| Pancreatic | 460 (2.7) | 185 (40.2) | 26 (5.7) | 30 (6.5) | 0 (0.0) | 156 (33.9) | 8 (1.7) | 36 (7.8) | 19 (4.1) |
| Prostate | 2130 (12.5) | 1398 (65.6) | 92 (4.3) | 258 (12.1) | 4 (0.2) | 112 (5.3) | 72 (3.4) | 103 (4.8) | 91 (4.3) |
| Rectal | 648 (3.8) | 374 (57.7) | 28 (4.3) | 66 (10.2) | 69 (10.6) | 58 (9.0) | 19 (2.9) | 20 (3.1) | 14 (2.2) |
| Renal | 557 (3.3) | 290 (52.1) | 27 (4.8) | 39 (7.0) | 5 (0.9) | 94 (16.9) | 11 (2.0) | 61 (11.0) | 30 (5.4) |
| Stomach | 308 (1.8) | 156 (50.6) | 18 (5.8) | 30 (9.7) | 0 (0.0) | 71 (23.1) | 1 (0.3) | 16 (5.2) | 16 (5.2) |